At a time when life sciences supply chain strategy is being stress-tested by geopolitical volatility, Tredence's supply chain experts Abhijay Datta and Hemanth Holla argue that most pharma, biotech, and medical device organizations are operating on planning tools built for a far more stable world. In this piece published on MD+DI, they lay out four interconnected pillars that define a genuinely intelligent life sciences supply chain: a unified, decision-grade data foundation; continuous geopolitical risk sensing through embedded AI; dynamic scenario and trade-off modeling that runs always-on rather than in periodic cycles; and closed-loop, semi-autonomous action driven by AI agents with human-in-the-loop governance. Together, these pillars shift organizations from reacting to disruptions after impact to anticipating and containing them before they propagate.

Read the full article on MD+DI →

Begin your journey to Intelligent Supply Chain

Tredence's Life Sciences Supply Chain Command Center brings the four-pillar framework to life as a production-ready solution. It delivers real-time visibility across planning, sourcing, and fulfilment, with intelligent alerts, automated root cause analysis, and AI-driven recommendations that compress decision cycles by up to 80%. Built on a scalable, cloud-native data foundation, the Command Center connects fragmented operational data across production, inventory, quality, and procurement with external signals including supplier health, trade policy shifts, and logistics constraints, giving supply chain leaders a single, decision-grade view of their network.

Explore Tredence's Life Sciences Supply Chain capabilities →